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Diabetic Ketoacidosis commonly presents with hyponatremia, but hypernatremia is a rare entity. We report a unique case
of a 50-year-old woman admitted with altered sensorium with blood glucose 979 milligrams/deciliter, serum osmolarity 363
mOsm/kilograms, and serum sodium 144 milliequivalents/liter. Patient was given initial bolus of isotonic saline and continued
on half isotonic saline for correction of hypernatremia along with insulin infusion therapy. Patient was successfully treated with
intravenous fluids, insulin infusion, and the altered sensorium was resolved without any sequelae. This case illustrates a teaching
point in the use of intravenous fluids for the treatment of Diabetic Ketoacidosis with hypernatremia.

1. Introduction
In the increasingly expanding population, Diabetes Mellitus
accounts for 20-50% of new-onset diabetic patients in young
adult population [1]. And Diabetic Ketoacidosis (DKA)
continues to be the most severe medical emergency requiring
admission to Intensive Care Unit (ICU). Here we discuss
a unique case about a 44-years-old female presenting with
hypernatremia in DKA secondary to severe hypotonic fluid
loss and the management for this condition.

2. Case Presentation
A 50-years-old African female with medical history of hypertension, Diabetes Mellitus Type-2, and Major Depression
Disorders presented with intractable vomiting and altered
sensorium. About eight–ten hours prior to presentation,
patient started to experience multiple episodes of nonbloody
& nonbilious vomiting along with nausea leading to fatigue
and altered sensorium requiring to be transported to hospital.
Prior to initiation of the symptoms, she had suppressed
appetite and skipped her dosage of Metformin 500 mg
because of decreased oral intake and emesis. On presentation,

patient was obtunded, responsive to pain, and poorly receptive to verbal stimuli. She had blood pressure of 123/81 mm
Hg, respiratory rate of 25 breaths per minute, heart rate of
124 beats/minute, pulse oximetry of 97% on ambient air, and
temperature of 97.6 Fahrenheit. On physical exam, she had
mild distress, tachycardia, tenderness around epigastric area
on deep palpation, and dehydration with poor skin turgor.
Due to state of presentation, computed tomography (CT)
scan of the head showed no intracranial pathologies or
cerebral edema presence. Venous blood gas showed pH 7.39,
pCO2 31 mm Hg, pO2 52 mm Hg, HCO3 18.8, sodium 148
mmol/L, potassium 3.5 mmol/L, glucose 750 mg/dl, and
lactate 2.9 mmol/L. Initial biochemistry analysis showed
serum sodium 144 meq/L, potassium 4.8 meq/L, chloride 98
meq/L, bicarbonate 14 meq/L, albumin 4.2 g/L, and serum
glucose 979 mg/dl. Corrected sodium was calculated to be
158 meq/L, anion gap 32, delta gap: 2, and serum osmolality
363 mOsm/kg. Ketone bodies were strongly positive in the
blood and urine. Table 1 shows additional biochemical values
appropriate to the time interval.
Patient had received initial fluid resuscitation and, later,
she was admitted to ICU requiring administration of normal
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Table 1
T: 0
(On admission)

T: 6

T: 12

T: 16

T: 20

Sodium (meq/L)

144

159

158

158

159

Potassium (meq/L)

4.8

3.4

3.9

4.1

3.9

98

120

121

121

122

Electrolytes

Chloride (meq/L)
Bicarbonate (meq/L)

14

17

22

24

27

Calcium (mg/dl)

9.7

9.5

9.6

9.3

9.2

Phosphorus (mg/dl)

7.6

1.8

2.4

3

2.9

Magnesium (mg/dl)

3.1

2.4

2.1

2.2

1.9

979

554

355

218

159

Serum Glucose (mg/dl)
Albumin (G/L)

4.2

3.7

---

3.7

3.9

Creatinine (mg/dl)

2.43

1.57

1.39

1.47

1.37

Corrected Sodium (meq/L)

158

166

162

160

159

Anion Gap
Serum Osmolality (Calculated)
mOsm/Kg

32

22

16

13

10

363

363

347

338

336

∗T: Time denoted in hours from admission.

saline, initiation of intravenous insulin infusion, and electrolytes repletion. Serum glucose levels were appropriately
improving with goal of 50-70 mg/dl per hours, though serum
sodium continued initially to peak before the values started to
decrease. Patient started to be alert, awake, and responsive to
commands with tolerating oral diet and improvement from
admission assessment. Serum sodium levels were gradually
controlled within normal range over 72 hours within admission. Patient was eventually transferred to medical floor for
optimization of diabetic medication and education prior to
discharge without any further events.

3. Discussion
As hyperglycemia-induced osmotic fluid and osmotic diuresis occur between compartments, electrolyte disturbances are
expected resultant in patients with DKA. In addition, they
may present with complex metabolic interplay: Ketoacidosis
or Ketoalkalosis [2].
Patients with DKA commonly present with hyponatremia
on admission to the hospital. Uncontrolled plasma glucose
causes increase in plasma tonicity, creating a driving force
for the movement of water from intracellular space to extracellular space, which dilutes the extracellular concentration
of sodium. In addition, secretion of vasopressin limits water
loss via kidney, which all leads to hyponatremia [1, 3], while
hypernatremia in DKA occurs from hypotonic renal losses,
which is water excretion in excess of sodium and potassium,
due to glycosuria-induced osmotic diuresis and inappropriate
water replacement [3]. As per consensus statement guidelines, a correction factor of 1.6 mg per deciliter is added to
the measured plasma sodium concentration for each 100 mg
per deciliter of glucose above 100 mg per deciliter to account
for the dilution effect of glucose. Corrected serum sodium
provides a handy tool in monitoring and management during

acute hyperglycemic crisis [1, 3]. In cases of high aniongap acidosis, delta-delta or delta gap is employed to evaluate
additional underlying metabolic acid-base disorder [1]. In our
case, the anion gap was 32 mmol/liter and change (delta)
in the concentration of bicarbonate ions was 10 mmol/liter
with a calculated delta ratio of 2, which interprets anion-gap
acidosis with concurrent metabolic alkalosis. In ketoacidosis,
there is 1:1 correlation between the increase in the anion gap
and the decrease in the concentration of bicarbonate, but the
patient had severe hypernatremia that may have contributed
to the anion gap causing increased delta gap [1].
There are numerous pediatric cases reported about hypernatremia in DKA secondary to new-onset Type 1 Diabetes
Mellitus, carbonated carbohydrate beverages, and herbal
product ingestion [4]. Most of these cases presented with the
patient exhibiting altered sensorium, attributing to hypernatremia causing severe cellular dehydration with central
nervous system (CNS) [4].
Some studies suggest altered sensorium determined by
the levels of serum sodium, especially in non-ketotic hyperglycemia hyperosmolar syndrome [5, 6].
Management of hypernatremia in DKA constitutes of
infusing 0.9% normal (isotonic) saline, at a rate of 15-20
milliliters per kilogram per hour or 1-1.5 liters during the
first hour, to maintain effective plasma osmolality, in addition
to supplementation of potassium [1, 7, 8]. Subsequently,
fluids should be changed to 0.45% sodium chloride as the
corrected sodium concentration may be in excess of 145
mmol/liter. One should take precautions to avoid risking
cerebral edema, from overcorrecting acute hypernatremia, by
decreasing plasma sodium concentration by 2 mol/liter/hour
until plasma concentration is 145 mmol/liter [7].
In conclusion, our case provides clinicians with a refresher on the use of corrected sodium to guide the fluid therapy, altered sensorium driven by acute hypernatremia, and
approach to the management of this condition.
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